Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MYGN
#2806
Myriad Genetics, Inc. - Common Stock
6.2
9
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.32%
Monthly Change
+47.65%
6 month change
+4.83%
Year Change
-23.94%
Previous Close
6.3
1
Open
6.3
0
Low
6.2
5
High
6.3
7
Volume
329
Markets
US Stock Market
Healthcare
Diagnostics & Research
MYGN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
92.18 M
93.04 M
93.21 M
93.51 M
94.45 M
94.45 M
Valuation ratios
Enterprise value
785.11 M
419.67 M
648.04 M
545.38 M
420.92 M
589.03 M
Price to earnings ratio
-7.92
-1.24
-1.67
-1.56
-1.04
-1.46
Price to sales ratio
0.97
0.58
0.8
0.69
0.5
0.7
Price to cash flow ratio
128.62
21.62
292.56
316.38
169.65
236.75
Price to book ratio
0.28
0.19
0.3
1.55
0.29
0.4
Enterprise value to EBITDA ratio
-7 851.13
-1.62
-2.13
-1.64
-0.97
-1.9
Profitability ratios
Return on assets %
-0
-0.49
-0.04
-0.01
-0.05
-0.05
Return on equity %
-0
-0.85
-0.07
-0.02
-0.1
-0.1
Return on invested capital %
-0.05
-279.25
-21.33
-4.64
-28.68
-28.68
Gross margin %
68.5
71.23
69.91
69.97
68.66
68.66
Operating margin %
-14.8
-154.48
-11.33
-2.72
-15.32
-15.32
EBITDA margin %
-7.4
-147.77
-5.15
16.06
-9.03
-9.03
Net margin %
-0.05
-155.09
-13.32
-3.77
-17.02
-17.02
Liquidity ratios
Quick ratio
1.71
1.28
2.12
2.26
2.19
2.19
Current ratio
1.9
1.42
2.33
2.49
2.4
2.4
Inventory turnover
2.21
2.14
2.05
2.03
2.15
2.15
Asset turnover
0.19
0.31
0.29
0.29
0.29
0.29
Solvency ratios
Debt to assets ratio
0.06
0
0.16
0.17
0.18
0.18
Debt to equity ratio
0.08
0
0.32
0.33
0.36
0.36
Long term debt to total assets ratio
—
—
0.16
0.17
0.18
0.18
Long term debt to total equity ratio
—
—
0.32
0.33
0.36
0.36
Per share metrics
Operating cash flow per share
-0.18
-0.15
0.23
0.11
-0.17
0.03
EBIT per share
-0.32
-3.56
-0.25
-0.06
-0.33
-4.2
EBITDA per share
-0.16
-3.4
-0.11
0.36
-0.19
-3.35
Total debt per share
0.65
0
1.28
1.29
1.28
1.28
Cash per share
1
0.8
1.56
1.62
1.33
1.33
Net current asset value per share
3.14
3.07
3.7
3.59
3.34
3.34
Tangible book value per share
7.71
4.2
4
3.97
3.6
3.6
Working capital per share
1.49
0.91
2.11
2.15
1.95
1.95
Book value per share
7.71
4.2
4
3.97
3.6
3.6
News
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?
Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock
Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh
MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans
Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN)
Myriad Genetics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MYGN) 2026-05-08
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call Transcript